Do the 8-year PACE-A results support a claim of equivalent long-term cancer control between SBRT and prostatectomy?

Or does reliance on BCF as the primary endpoint limit that conclusion? This question is part of our ASTRO 2026 collaboration, inspired by the Plenary Session Presentation "Efficacy of Radical Prostatectomy Versus Stereotactic Body Radiotherapy (SBRT) for Localised Prostate Cancer: Results from an international Phase III Randomised Controlled Trial (PACE - A)" by Dr. Nicholas van As, MD, MB